Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-12-05

FDA Approved: LATANOPROST — Supplemental Application (Somerset Therapeutics, LLC)

View source ↗

Summary

The FDA approved a supplemental application for latanoprost from Somerset Therapeutics, LLC. Latanoprost is used to lower intraocular pressure in open-angle gla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Latanoprost (Latanoprost)

Snippet

SUPPL AP for LATANOPROST (LATANOPROST)